Summary
We studied the expression of the hematopoietic progenitor cell antigen CD 34 in six patients with refractory anemia with excess of blasts (RAEB), five patients with RAEB in transformation (RAEB-T), and seven patients with chronic myelomonocytic leukemia (CMML). Immunocytochemical labeling of bone marrow cells was performed by an indirect immunoperoxidase method with preservation of morphological details. The cells were stained with May-Grünwald-Giemsa, photographed, destained, and immunolabeled by the immunoperoxidase technique. We found 1.5±0.5% blasts and 0.8±0.4% CD 34+ blasts in normal bone marrow. The CD 34 positivity of blasts was 53±9%. The patients with RAEB showed 1.7±1.4% CD 34+ blasts. The CD 34 positivity of blasts (11.8±5.6%) was lower than in normal bone marrow. The patients with RAEB-T had a higher percentage of CD 34+ blasts (7.3∓3.4) and a higher CD 34 positivity of blasts (28.2±14.6%) than patients with RAEB. The CMML patients showed a percentage of CD 34+ blasts and a CD 34 positivity of blasts in the range of RAEB. We found an increase of promonocytes (PMC) in 5/7 patients. In some patients the PMC were CD 34 positive. Our results indicate that the increase of blasts in REAB is related to CD 34-negative blasts. With progression to RAEB-T the percentage of CD 34-positive blasts increased. Some of the CMML patients also showed a population of CD 34-positive PMC. A clone of undifferentiated CD 34-positive cells is characteristic for patients with these types of myelodysplasia.
Similar content being viewed by others
References
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189–199
Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH (1984) Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133:157–165
Clark RE, Smith SA, Jacobs A (1987) Myeloid surface antigen abnormalities in myelodysplasia: relation to prognosis and modification by 13-cis retinoid acid.J Clin Pathol 40:652–656
Fenaux J, Jouet JP, Zandecki M, Lai JL, Simon M, Pollet JP, Bauters F (1987) Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors. Br J Haematol 65:101–106
Goasguen JE, Bennett JM, Cox C, Hambley H, Mufti G, Flandrin G (1991) Prognostic implication and characterization of the blast cell population in the myelodysplastic syndrome. Leuk Res 15:1159–1165
Guyotat D, Campos L, Thomas X, Villa L, Shi ZH, Charrin C, Gentihomme O, Fiere D (1990) Myelodysplastic syndromes: a study of surface markers and in vitro growth pattern. Am J Hematol 34:26–31
Kantarjian HM, Shtalrid M, Kurzrock R, Blick M, Dalton WT, LeMaistre A, Stass SA, Credie KB, Gutterman J,Freireich EJ, Talpaz M (1988) Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Am J Med 85:639–644
Kristensen JS, Hokland P (1990) Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes. Br J Haematol 74:270–276
List AS, Spier CM, Cline A, Doll D, Garwal H (1991) Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype. Br J Haematol 78:28–34
Oertel J, Kastner M, Bai AR, Kleiner S, Huhn D (1992) Analysis of chronic lymphoid leukaemias according to FAB. Leuk Res 16:919–927
Oertel J, Kleiner S, Huhn D (1993) Immunotyping of blasts in refractory anaemia with excess of blasts. Br J Haematol 84:305–309
Storniolo AM, Moloney WC, Rosenthal DS, Cox C, Bennett JM (1990) Chronic myelomonocytic leukemia. Leukemia 4:766–770
Strauss LC, Rowley SD, la Russa VF, Sharkis SJ, Stuart RK, Civin CI (1986) Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol 14:878–886
Woods JC, Springs AJ, Harris H, McGee JC (1982) A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with Ca 1 antibody. Lancet 2:512–514
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oertel, J., Oertel, B., Beyer, J. et al. CD 34 Immunotyping of blasts in myelodysplasia. Ann Hematol 68, 77–80 (1994). https://doi.org/10.1007/BF01715135
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01715135